AbbVie

$72.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.16 (-1.57%) Today
+$0.03 (+0.04%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell AbbVie and other stocks, options, ETFs, and crypto commission-free!

About ABBV

ABBVIE INC., also called AbbVie, is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. Read More The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Employees
30,000
Headquarters
North Chicago, Illinois
Founded
2011
Market Cap
100.28B
Price-Earnings Ratio
13.75
Dividend Yield
6.50
Average Volume
19.22M
High Today
$75.06
Low Today
$70.71
Open Price
$71.57
Volume
12.29M
52 Week High
$97.86
52 Week Low
$62.55

Collections

ABBV News

MarketWatchMar 27

This portfolio manager draws on 2008 lessons to find stocks that will outlast a pandemic

Corrects reference to Nestlé and performance of Levin Easterly versus its benchmarks. Our call of the day comes from a portfolio manager who draws on what he l
100
ReutersMar 26

Roundup: AbbVie paid CLO over $15 mln, Amex paid CLO $8.5 mln in 2019

Here are some of the latest lawyer compensation packages disclosed by large companies in proxy filings with the U.S. Securities and Exchange Commission. All fis
1,662
BenzingaMar 23

Global Antibiotics Market 2020-2024 | Evolving Opportunities with Abbott Laboratories and AbbVie Inc. | Technavio

The global antibiotics market is poised to grow by USD 4.44 billion during 2020-2024, progressing at a CAGR of over 3% during the forecast period. Request free
332

ABBV Earnings

$0.00
$0.78
$1.55
$2.33
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
per share
Actual
Expected Apr 24, Pre-Market

People Also Bought

You May Also Like

More ABBV News

ReutersMar 23

BRIEF-Abbvie - VIALE-A Trial Of Venclexta In Combination With Azacitidine Versus Azacitidine In Combination With Placebo Met Its Dual Primary Endpoints

March 23 (Reuters) - Abbvie Inc: * ABBVIE INC - VIALE-A TRIAL OF VENCLEXTA IN COMBINATION WITH AZACITIDINE VERSUS AZACITIDINE IN COMBINATION WITH PLACEBO MET I
1,917
ReutersMar 23

BRIEF-Abbvie - Extends Expiration Date Exchange Offers For Allergan Notes From On March 27, 2020 To April 10, 2020

March 23 (Reuters) - Abbvie Inc: * ABBVIE - EXTENDS EXPIRATION DATE EXCHANGE OFFERS FOR ALLERGAN NOTES FROM ON MARCH 27, 2020 TO APRIL 10, 2020 * ABBVIE INC -
1,044
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.